Insulin Delivery
Closed-loop system tied to better glycemic control vs. standard therapy in type 2 diabetes
Adults with type 2 diabetes using a fully closed-loop automated insulin delivery system have a higher time in range than those receiving conventional insulin therapy, according to findings published in Diabetic Medicine.
VIDEO: Tips for using automated insulin delivery during pregnancy
SAN DIEGO — In this video exclusive, three experts on type 1 diabetes in pregnancy offer tips for off-label use of automated insulin delivery systems for improving glycemic targets and quality of life during pregnancy.
VIDEO: DIY open-source insulin delivery systems beneficial in type 1 diabetes
SAN DIEGO — In this video exclusive, Dana Lewis, a founder of OpenAPS, discusses how open-source, automated, closed-loop insulin delivery systems can benefit people living with type 1 diabetes.
ADA issues practical advice for use of automated insulin delivery systems
Open communication between stakeholders and patient education are two underlying themes in a new series of recommendations provided in a consensus report on the use of automated insulin delivery systems.
FDA clears tubeless hybrid closed-loop insulin delivery system for young children
The FDA has cleared the first tubeless hybrid closed-loop insulin delivery system for use by children aged 2 to 5 years with type 1 diabetes, according to an industry press release.
Better overnight time in range, worse sleep quality with closed-loop insulin delivery
Older adults with type 1 diabetes using hybrid closed-loop insulin pump therapy had more time in range during sleep, but worse sleep quality compared with those using sensor-augmented therapy, according to study findings.
No changes in glucose, insulin delivery during menstrual cycle with artificial pancreas
A small group of women with type 1 diabetes using a hybrid closed-loop insulin delivery system maintained similar glycemic levels and insulin delivery throughout their entire menstrual cycle, according to study data
FDA clears first tubeless hybrid closed-loop insulin delivery system
The FDA has cleared the first tubeless hybrid closed-loop insulin delivery system for people with type 1 diabetes aged 6 years and older, according to a press release from Insulet.
‘We must lift the burden’: A century of insulin advances and challenges
This year marked the 100th anniversary of insulin’s discovery in 1921, and professional societies and stakeholders have highlighted advances in formulations and delivery. Yet today, global insulin access and affordability issues persist.
Nearly one-third of adults prescribed hybrid closed-loop system do not initiate auto mode
About 31% of a group of adults with type 1 diabetes prescribed a hybrid closed-loop insulin delivery system never initiated auto mode, and half of the never initiated group consisted of Black and Hispanic patients, according to study data.